Tag Archives: WRD

fixed income investments

The Jeep Wrangler is as traditional as a Thanksgiving dinner. That means you can’t really change it too much or people get really upset.

So don’t be too surprised when you look at the all-new, completely redesigned 2018 Jeep Wrangler and find yourself wondering where the changes are. But there actually is a lot that’s new under that body that still looks like a grizzled World War II veteran.

First, it will be available as a mild hybrid with a four-cylinder engine. To some, a hybrid Wrangler might seem as weird as tofu turkey, but, parent company Fiat Chrysler (FCAU) insists, the battery-boosted system will give this Wrangler more pulling power than you’ll get from the V6 engine, plus excellent fuel economy. As a mild hybrid, it won’t ever run electric power alone, but batteries will provide some extra push to assist the gasoline engine when starting off and under heavy strain. Official fuel economy figures have yet to be revealed.

The V6 engine will still be available and, for the first time on the Wrangler in the United States, so will a diesel engine option.

fixed income investments: RetailMeNot, Inc.(SALE)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of RetailMeNot Inc (NASDAQ: SALE) got a boost, shooting up 12 percent to $8.42. RetailMeNot announced after Thursday’s close it has entered into an agreement to acquire GiftCard Zen, a secondary marketplace for gift cards. The company reported preliminary Q1 revenue of $54 million to $54.5 million and FY16 revenue of $228 million to $241 million.

  • [By Demitrios Kalogeropoulos]

    As for individual stocks, RetailMeNot (NASDAQ:SALE) and SUPERVALU (NYSE:SVU) attracted heavy investor interest following merger and acquisition news.

fixed income investments: comScore Inc.(SCOR)

Advisors’ Opinion:

  • [By Paul Ausick]

    comScore Inc. (NASDAQ: SCOR) dropped more than 10% on Tuesday to record a new 52-week low of $20.81. The stock closed at $23.22 on Monday. Volume was about 9 times the daily average of around 470,000 shares. The company’s stock will be de-listed from Nasdaq effective February 8 unless the company receives a stay from the exchange.

fixed income investments: Lithium Americas Corp. (LACDF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Still, reading between the lines, it’s been clear which names he has liked over the months and years. Lithium Americas (OTCQX:LACDF) and SQM (NYSE:SQM) are prime examples. Consider that LAC shares have more than doubled from an early July low of C$0.78 (it closed at C$1.70 on Sept. 15th) when rumblings suggested that SQM might not move forward on the LAC/SQM Cauchari-Olaroz project. Joe was among the first to squash those rumors, setting up what turned out to be a highly profitable buying opportunity. SQM is up 120% in the past 12 months (by comparison, the Global X Lithium ETF (LIT) is up 54%, and the S&P 500 Index is up 16%).

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

fixed income investments: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

fixed income investments: Intuit Inc.(INTU)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Morgan Stanley reported on Wednesday that it has downgraded financial management solution provider Intuit Inc. (INTU).

    The firm has cut its rating on INTU to “Underweight,” and has given the company a $62 price target. This price target suggests a 6% decline from the stock’s current price of $66.30. This downgrade reflects the company’s slowing growth of its tax business.

    Intuit shares were mostly flat during pre-market trading Wednesday. The stock is up 11% YTD.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Intuit Inc. (NASDAQ: INTU) which jumped nearly 7% to $137.88. The stocks 52-week range is $101.81 to $140.25. Volume was 4.8 million on the day compared to the average of 1.9 million.

  • [By Monica Gerson]

    Intuit Inc. (NASDAQ: INTU) reported upbeat results for its third quarter and raised its FY16 guidance. Intuit shares dropped 2.15 percent to $105.00 in the after-hours trading session.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

fixed income investments: Cimpress N.V(CMPR)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares ofCimpress NV(NASDAQ:CMPR)climbed 14.6% in 2016,according to data from S&P Global Market Intelligence, as the mass customization specialist steadfastly pursued its novel long-term efforts to generate shareholder value.

investment tips

What happened

Shares of Innoviva (NASDAQ:INVA), a biotechnology royalty company that develops respiratory therapeutics and is perhaps best known as GlaxoSmithKline’s (NYSE:GSK) development partner for its multiple next-generation COPD and asthma products, fell as much as 11% on Thursday. The reason behind Innoviva’s bad day can be traced to a proxy battle with activist hedge fund Sarissa Capital Management over seats on its board.

So what

According to a press release from Sarissa Capital on Wednesday evening (since Innoviva has thus far declined to comment), Innoviva had agreed to settle its proxy fight by allowing Sarissa two board seats. However, according to reports, Innoviva continued to lobby for votes from shareholders without disclosing the fact that a deal had been reached with Sarissa Capital. Sarissa sent over the signed paperwork to Innoviva on Wednesday afternoon agreeing to the settlement but was told by Innoviva that it would renege on its offer to place two of Sarissa’s choices on its board. When the smoke cleared, Innoviva had narrowly garnered enough votes to keep its own members on the board.

investment tips: The Joint Corp.(JYNT)

Advisors’ Opinion:

  • [By Monica Gerson]

    Joint Corp (NASDAQ: JYNT) is estimated to post a quarterly loss at $0.28 per share on revenue of $4.13 million.

    Synacor Inc (NASDAQ: SYNC) is projected to post a quarterly loss at $0.03 per share on revenue of $30.00 million.

investment tips: Microchip Technology Incorporated(MCHP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    My colleague Tiernan Rey at Barron’s Tech Trader Daily quoted B. Rileys Craig Ellis in a post today, who called the selloff yesterday an unusually attractive entry opportunity forApplied Materials andMicrochip Technology (MCHP) buyers.

  • [By Ben Levisohn]

    Microchip Technology (MCHP) sunk to the bottom of the S&P 500 today as semiconductor stocks got clobbered.

    Getty Images

    Shares of Microchip Technology tumbled 7.5% to $61.23 today, while the S&P 500 declined 0.4% to 2,191.08. The SPDR S&P Semiconductor ETF (XSD) fell 4.8% to $52.29, while the VanEck Vectors Semiconductor ETF (SMH) dropped 4.8% to $67.68.

    Today’s slaughter comes two days after Microchip Technology narrowed its third-quarter guidance. Stifel’s Kevin Cassidy and team had the details:

    Microchip upwardly revised its December ending quarter…Non-GAAP EPS guidance was updated to $0.87 – $0.94 compared to $0.85 – $0.95 previously…The According to management, the upside is coming from better than expected integration of recent acquisitions. Management pointed out that significant gross margin improvements may be recognized as the inventory of higher cost products from the now closed Micrel fab is depleted. We have revised our revenue and non-GAAP earnings estimates and increased our 12-month target price to $70.

    Microchip Technology’s market capitalization fell to $13.2 billion from $14.3 billion yesterday. It report net income of $324 million on sales of $2.2 billion in fiscal 2016.

     

investment tips: ENGlobal Corporation(ENG)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested shorting small cap energy engineering and professional services stock ENGlobal Corp (NASDAQ: ENG):

investment tips: Xerox Corporation(XRX)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Xerox Corp. (NYSE: XRX) which rose 3.8% to $30.56. The stocks 52-week range is $22.90 to $30.76. Volume was 3.8 million compared to its average volume of 2.3 million.

  • [By Paul Ausick]

    Xerox Corp. (NYSE: XRX) dropped about 23% on Tuesday to post a new 52-week low of $6.46 after closing at $8.73 on Friday. The dip was the result of the company’s completed separation into two firms this morning. After the early drop shares had gained around 17% by late afternoon, probably on the strength of a cash payment of $1.8 billion.

investment tips: Prima BioMed Ltd(PBMD)

Advisors’ Opinion:

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) shares dipped 38.59% to touch a new 52-week low of $1.44 after the company reported top-line analysis of CVac Phase 2 trial.

  • [By Monica Gerson]

    Prima Biomed (NASDAQ: PBMD) dropped 38.17% to $1.45 after the company reported top-line analysis of CVac Phase 2 trial.

    Tower Group International (NASDAQ: TWGP) plummeted 24.31% to $10.49. Tower Group announced its plans to release its Q2 results during the week of October 7, 2013. FBR Capital downgraded the stock from Outperform to Market Perform.

investment tips: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

small cap stocks

Buffetts 8 Nuggets of Investing Advice: Berkshire Shareholder Letter 2017

Why Trump Advisor Scaramucci Hates DOL Fiduciary Rule

Ron Rhoades: DOL Fiduciary Rule Is as Good as Dead (for Now)

New York regulators have fined the Lincoln Financial Group $1.5 million for the company’s failure to fix widespread claims-processing errors and for delayed reporting of the problem to state officials.

A consent order announced Tuesday by the state Department of Financial Services also said that Lincoln Financial, headquartered in Radnor, Pennsylvania, and its life insurer-affiliates have paid $50.7 million to the beneficiaries of New York policyholders that was delayed because of the claims-processing problems.

Originally published on New York Law Journal. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources STRAIGHT-THROUGH PROCESSING FOR THE FINANCIAL SERVICES INDUSTRY

STP can be described as electronically capturing and processing transactions in one pass, from the point of first ‘deal’ to final settlement.

small cap stocks: Liberty Global plc(LBTYA)

Advisors’ Opinion:

  • [By Alex Webb]

    Kabel Deutschland is a key part of Vodafones expansion strategy as the carrier looks for ways to boost revenue and lock in customers with Internet and television offers in addition to wireless service. Kabel Deutschland is the biggest cable company in Germany, Vodafones largest market, and had drawn a rival bid from John Malones Liberty Global Plc. (LBTYA)

small cap stocks: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

small cap stocks: Golden Ocean Group Limited(GOGL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    StarBulk Carriers (SBLK) and Safe Bulkers (SB) have more than tripled during the past 12 months, while Golden Ocean Group (GOGL) has more than doubled. So it must be time for an upgrade right?

small cap stocks: Buffalo Wild Wings Inc.(BWLD)

Advisors’ Opinion:

  • [By Peter Graham]

    After the market closed yesterday, small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q4 2016 earnings with shares falling by mid single digit percentagesin after hours trading. The Company apparently beat expectations on earnings, but fell short of expectations for comps. Likewise, the stock has already had a very good run meaning expectations were super high.Take a look at the following long term chart which shows Dave & Busters Entertainmentsshare performanceascompared to potential peers such as Buffalo Wild Wings (NASDAQ: BWLD) and upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK):

  • [By Lisa Levin]

    Buffalo Wild Wings (NASDAQ: BWLD) shares were also up, gaining 20 percent to $121.75 after the company posted better-than-expected earnings for its third quarter and raised its forecast for the full year.

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment being a pretty steady performer up until June while potential peer, upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), took off last yearand Buffalo Wild Wings (NASDAQ: BWLD) has started to fall off:

  • [By Peter Graham]

    A long term performance chart shows Dave & Busters Entertainment doubling in valuewhile potential peer, small cap upscale gentlemen’s clubs and restaurant ownerRCI Hospitality Holdings, Inc (NASDAQ: RICK), began to takeoff last yearand small capBuffalo Wild Wings (NASDAQ: BWLD) has basically been range bound for the last four days:

  • [By Rich Duprey]

    Is Netflix (NASDAQ: NFLX) original programming likeThe Crown more interesting to watch than the Golden State Warriors’ bid to run away with the NBA championship? Could be, as the movie streaming giant continues to add to its subscriber base while sports bars like Buffalo Wild Wings (NASDAQ:BWLD) lose customers quarter after quarter.

small cap stocks: Enviva Partners, LP(EVA)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

small cap stocks: Douglas Dynamics Inc.(PLOW)

Advisors’ Opinion:

  • [By Lisa Levin] Related PLOW 18 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Gainers For Tuesday Douglas Dynamics Inc (PLOW) Chairman, President and CEO James L Janik Bought $59,5 of … (GuruFocus)
    Related TIF Your Luxury Brands Earnings Cheat Sheet Guggenheim Initiates Coverage On 21 Retail Stocks Tiffany & Co: China Market Will Drive Earnings Growth For The Next Decade (Seeking Alpha)

    It’s critical to know whether a stock you plan on buying has an ex-dividend status, because in case it does, the dividend would be paid out to the seller. The person who owns the stock on the ex-dividend date will be awarded the payment, which means that you’ll have to wait for the next dividend cycle to receive your first dividend payout from the company.

Top 10 Safest Stocks To Invest In 2018

Papa John’s International Inc. (NASDAQ:PZZA), the recognized quality leader in the pizza category, posted excellent quarterly results including an 8.52% increase in total revenues. Total revenues for the first nine months increased 4.1%.

Papa John’s is the world’s third-largest pizza delivery company and offers different pizza styles, topping choices and side items including chicken preparations, desserts and beverages. During the third quarter, the company had 4,971 Papa John’s restaurants operating in all 50 states and in 44 international countries and territories.

Strong third-quarter results

On Nov. 1, 2016, the Louisville, Kentucky-based company reported its financial results for the third quarter ended Sept. 25. The company’s total revenues increased 8.52% to $422.44 million, compared to $389.28 million for the comparable prior-year period. Revenues from domestic company-owned restaurant sales increased 10.54%.

Top 10 Safest Stocks To Invest In 2018: United Parcel Service Inc.(UPS)

Advisors’ Opinion:

  • [By JJ Kinahan]

    While we’re on the subject of holiday shopping, the huge influx of online purchases apparently is causing problems for carriers such as United Parcel Service, Inc. (NYSE: UPS) and FedEx Corporation (NYSE: FDX), the Washington Post reported. UPS warned last week that some deliveries would be delayed one or two days as staffers worked extended hours to manage the rush. UPS expects its holiday load to rise 5 percent, to 750 million packages, this holiday season, while FedEx says it’s planning for up to 400 million parcels. Amazon.com Inc’s (NASDAQ: AMZN) deliveries are also experiencing delays. Americans spent a record $6.59 billion online on Cyber Monday.

  • [By Todd Campbell, Demitrios Kalogeropoulos, and Reuben Gregg Brewer]

    In the case of these three stocks, however, it may be worth taking a gamble. Our contributors think catalysts at Regeneron Pharmaceuticals (NASDAQ:REGN), Royal Dutch Shell (NYSE:RDS-B), and United Parcel Service (NYSE:UPS) can get them back to their winning ways. Read on to find out if these down-and-out stocks are right for your portfolio.

  • [By Todd Shriber, ETF Professor]

    “The fourth quarter may be the index’s best opportunity to turn around its anemic 2017,” said Direxion. “Over the past five years, the index’s Q4 performance averaged over 7 percent growth and only ended the quarter down once in that span; in 2015. Delivery companies like FedEx Corp. (NYSE: FDX) and United Parcel Service Inc. (NYSE: UPS) typically drive the Index around the end of the year.”

Top 10 Safest Stocks To Invest In 2018: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Non-cyclical consumer goods & services sector was the top gainer in the US market on Wednesday. Top gainers in the sector included Cia Energetica de Minas Gerais CEMIG-ADR (NYSE: CIG), Companhia Paranaense de Energia (ADR) (NYSE: ELP), and NRG Energy Inc (NYSE: NRG).

  • [By Ben Levisohn]

    NRG Energy (NRG) soared to the top of the S&P 500 today.

    Getty Images

    NRG Energygained 4.5% to $12.85 today, while the S&P 500 advanced 0.2% to 2,262.53.

    In a note released on Dec. 15, Morgan Stanley’sStephen Byrd and team summarized the reasoning behind their overweight rating on NRG:

    NRG Energy (NRG, Overweight, $21 PT) FCF/Equity yield of ~35% and balanced upside from diversified market exposure, higher PJM capacity prices, fleet optimization, and debt reduction. NRG’s generation plus retail matching strategy is an underappreciated source of value, and provides stable cash flow despite current depressed power prices in Texas.

    NRG Energy’s market capitalization rose to $4.1 billion today from $3.8 billion yesterday. It reported a net loss of $6.4 billion on sales of $15 billion in 2015.

    NRG Energy was the Biggest Loser on Nov. 10, and the Hot Stock on Nov. 4.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Rich Duprey]

    I ran a screen to identify the best-performing stocks from the S&P 500 in January. The top three performers during the month were Alcoa (NYSE:AA), CSX (NASDAQ:CSX), and NRG Energy (NYSE:NRG). Let’s see why they were the big standouts and whether they can keep it going.

  • [By Ben Levisohn]

    NRG Energy (NRG) has gained 2.1% to $18.49 after getting raise to Buy from Neutral at Goldman Sachs.

    Skechers USA (SKX) has tumbled 5.4% to$28.35 after getting cut to Negative from Positive at Susquehanna.

Top 10 Safest Stocks To Invest In 2018: Skechers U.S.A., Inc.(SKX)

Advisors’ Opinion:

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Timothy Green]

    Shares of footwear company Skechers (NYSE:SKX) fell 18.6% in 2016, according to data provided byS&P Global Market Intelligence. A slowdown in growth and a string of mixed and negative earnings reports led investors to push down the stock.

  • [By Brian Withers] When the number one company in comfort-casual footwear,Skechers (NYSE:SKX) announced earnings last month, the headlines highlighted the first ever $1 billion quarter for the company. It seems investors weren’t impressed, though, as the stock continues to lag behind the market and has missed a nice run up over the past year.

  • [By Matt Hogan]

    Skechers USA Inc (NYSE: SKX) is expected to report earnings on Thursday after the market closes. The footwear company has generally traded lower over the last eight quarters in the face of decelerating revenue growth. The stock had been gaining some momentum in the early part of the year until Susquehanna's Sam Poser downgraded the company to a negative rating on March 29th. Poser warned that domestic wholesale growth would fall short of investor expectations and the stock has since fallen 15 percent.

Top 10 Safest Stocks To Invest In 2018: Old Point Financial Corporation(OPOF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, financial shares fell 0.13 percent. Meanwhile, top losers in the sector included Adams Natural Resources Fund Inc (NYSE: PEO), down 4 percent, and Old Point Financial Corporation (NASDAQ: OPOF) down 3 percent.

Top 10 Safest Stocks To Invest In 2018: Calavo Growers, Inc.(CVGW)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Agricultural Produce Companies

    Limoneira Company (NASDAQ: LMNR): -32.1 percent since 2011. Calavo Growers, Inc. (NASDAQ: CVGW): +168.2 percent since 2011.

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

  • [By Lee Jackson]

    Calavo Growers Inc. (NASDAQ: CVGW) had the man at the top buying stock last week. CEO Lecil Cole purchased 95,000 shares of the avocados and other perishable foods distributor at prices between $55.44 and $56.92 a share. The total for the purchase was set at $5 million. The stock closed the day last Friday at $58.30, in a52-week range of$48.745 to $71.48. The consensus price target is set at $73.17.

Top 10 Safest Stocks To Invest In 2018: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

Top 10 Safest Stocks To Invest In 2018: HTG Molecular Diagnostics, Inc.(HTGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares shot up 175 percent to $10.80 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.

  • [By Lisa Levin] Related HTGM Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline HTG Molecular Diagnostics Completes Initial Technical Feasibility Testing with QIAGEN … (GuruFocus)
    Related Mid-Afternoon Market Update: Dow Falls 50 Points; Micron Shares Jump Following Strong Earnings Report Mid-Day Market Update: ZAIS Group Gains Following Q4 Results; Xenon Pharmaceuticals Shares Decline Zais Group reports Q4 results (Seeking Alpha)
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares climbed 204.1 percent to $11.95 after surging 83.64 percent on Thursday. HTG Molecular Diagnostics reported a Q4 loss of $0.76 per share on revenue of $1.5 million.
    ZAIS Group Holdings, Inc. (NASDAQ: ZAIS) shares surged 52.6 percent to $3.45. ZAIS Group reported Q4 earnings of $0.29 per share on revenue of $16.73 million.
    Global Brokerage Inc (NASDAQ: GLBR) shares jumped 24.3 percent to $2.30.
    Regulus Therapeutics Inc (NASDAQ: RGLS) shares surged 20 percent to $1.50. Regulus Therapeutics’ Chairman bought 500,000 shares at $1.22 per share.
    Rocket Fuel Inc (NASDAQ: FUEL) shares gained 15.6 percent to $5.19.
    Akoustis Technologies Inc (NASDAQ: AKTS) rose 13.3 percent to $10.75 as the company agreed to acquire wafer manufacturing facility for $2.75 million in cash.
    TOP SHIPS Inc (NASDAQ: TOPS) shares gained 12.6 percent to $1.25.
    Inventure Foods Inc (NASDAQ: SNAK) jumped 10.4 percent to $4.46 after the company announced the strategic sale of Fresh Frozen Foods for $23.7 million in cash.
    CymaBay Therapeutics Inc (NASDAQ: CBAY) surged 8.7 percent to $4.14. Cymabay Therapeutics reported a Q4 loss of $0.30 per share.
  • [By Lisa Levin] Related HTGM 20 Biggest Mid-Day Losers For Thursday 25 Stocks Moving In Thursday's Pre-Market Session HTG Molecular Diagnostics Obtains CE Mark for its HTG EdgeSeq ALKPlus Assay EU (GuruFocus)
    Related SSH 15 Biggest Mid-Day Gainers For Wednesday 12 Biggest Mid-Day Losers For Tuesday Healthcare – Top 5 Gainers / Losers as of 11:00 am (Seeking Alpha) Gainers
    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) rose 63.6 percent to $3.50 in pre-market trading after the company disclosed that it has obtained CE marking in the EU for HTG EdgeSeq ALKPlus Assay.
    Sunshine Heart Inc (NASDAQ: SSH) rose 20.3 percent to $2.61 in pre-market trading after the company issued a business update regarding execution of its strategic growth plan.
    bebe stores, inc. (NASDAQ: BEBE) shares rose 11.1 percent to $4.29 in pre-market trading after the company disclosed that it is exploring strategic alternatives.
    Cancer Genetics Inc (NASDAQ: CGIX) rose 10.3 percent to $3.20 in pre-market trading after the company posted a narrower-than-expected quarterly loss.
    Five Below Inc (NASDAQ: FIVE) rose 8.8 percent to $41.50 in pre-market trading after the company reported better-than-expected earnings for its fourth quarter.
    FireEye Inc (NASDAQ: FEYE) rose 8 percent to $12.40 in pre-market trading. Goldman Sachs upgraded FireEye from Sell to Buy.
    PVH Corp (NYSE: PVH) shares rose 7.4 percent to $97.60 in pre-market trading after the company posted upbeat earnings for its fourth quarter and issued a strong earnings forecast.
    Bitauto Hldg Ltd (ADR) (NASDAQ: BITA) shares rose 7 percent to $26.00 in pre-market trading after dropping 1.30 percent on Wednesday.
    Pingtan Marine Enterprise Ltd (NASDAQ: PME) rose 6.6 percent to $4.50 in pre-market trading after gaining 0.48 pe
  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares were also up, gaining 136 percent to $2.95. HTG Molecular Diagnostics disclosed that its new direct-target sequencing chemistry will be launched in the first quarter.

  • [By Lisa Levin]

    HTG Molecular Diagnostics Inc (NASDAQ: HTGM) shares shot up 106 percent to $4.40 after the molecular profiling company confirmed regulatory approval for its products in Europe. HTG Molecular announced that it has obtained CE marking in the European Union for its HTG EdgeSeqALKPlus Assay EU, an in vitro diagnostic assay which is intended to measure and analyze mRNA ALK gene rearrangements in formalin-fixed, paraffin-embedded lung tumor specimens from patients previously diagnosed with non-small cell lung cancer.

Top 10 Safest Stocks To Invest In 2018: Surgical Care Affiliates, Inc.(SCAI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Surgical Care Affiliates Inc (NASDAQ: SCAI) shares were also up, gaining 16 percent to $56.55 after UnitedHealth Group Inc. (NYSE: UNH) disclosed that its unit agreed to acquire Surgical Care Affiliates for around $2.3 billion.

Top 10 Safest Stocks To Invest In 2018: BYD Company Limited (BYDDY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    In this video I analyze BYD ltd. (OTCPK:BYDDY) (OTCPK:BYDDF) to see whether it is a great long-term investment opportunity given it is probable that China switches completely to electric vehicles by 2030. I discuss the fundamentals, the margins and where those stand in comparison to Daimler (OTCPK: DDAIF).

  • [By SEEKINGALPHA.COM]

    BYD Co. (OTCPK:BYDDY) (OTCPK:BYDDF) (HK:1211)

    On December 4, BYD’s CEO Wang presented “The company’s SkyRail electric monorail at the Mayors Summit in Mexico City before 500 guests. This included government officials from over 93 cities, more than 40 mayors, NGO representatives, business leaders, and the media.”

  • [By SEEKINGALPHA.COM]

    Some already had their autonomous car bets made with positions in both Tesla and Nvidia (NASDAQ:NVDA) surmising those will be the big winners. They have good company. Trip Chowdhry of Global Equities Research summed up his thesis for autonomous transportation and transportation in general going forward as Winners: Tesla, Nvidia; and Losers: Mobileye (NYSE:MBLY) and all traditional automakers. All traditional automakers? That’s basically every automaker on the planet besides Tesla and maybe Fisker and BYD (OTCPK:BYDDY), that’s a lot of losers. Trip is a talented analyst. I’ve followed him for many years (see his ranking on TipRanks here). Even for him, that’s a pretty bold statement. It got me thinking, is Tesla’s lead in the race for autonomous cars so great that the race is effectively over? I wanted to find out if I was using traditional methodologies too much, overthinking my picks and missing out on the bigger winner, Tesla.

Top 10 Safest Stocks To Invest In 2018: CSI Compressco LP(CCLP)

Advisors’ Opinion:

  • [By Lisa Levin]

    CSI Compressco LP (NYSE: CCLP) shares dropped 15 percent to $7.90. CSI Compressco lowered its quarterly cash distribution to $0.1875 per outstanding common unit. CSI Compressco is expected to release its Q1 earnings results on Tuesday, May 9, 2017.

Top 10 Bank Stocks To Own For 2018

The November election caught me be surprise. I find it hard to complain about the resulting appreciation in the S&P, but now that it has cooled, I, like other investors, just don’t know enough about Trump’s policies to make an educated investment decision. I was looking at banks, as the ever-present rate hike looms on the horizon into 2017, but I can’t shake the feeling of a financials pullback. Industrials had a great run, but with a rate hike and dismal global outlook, I can’t be sure about that, either. Oil and energy plays looked good as well, but with global demand and constant commodity volatility, that’s a tough call, too.

To look for some direction, I went over Trump’s Cabinet appointments, and the Education Secretary caught my eye. Betsy DeVos was appointed as Education Secretary, and I believe her staunchly conservative policy bodes well for a trade on government-funded student loans. These loans carry an average 11% default/delinquency rate, provide below average coupon payments, and carry a higher repayment risk than most debt securities. This is because students aren’t able to make large payments, and have more forebadance/deferment options than regular debtors. For these reasons, I believe the timing is right to short Navient (NASDAQ:NAVI).

Top 10 Bank Stocks To Own For 2018: Noble Energy Inc.(NBL)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Noble Energy (NBL) : “Noble’s good. It’s a very well-run, conservative company. It should do well in this environment.”

    Himax Technologies (HIMX) : “That area is so red-hot. I think it’s fine, but I like Cypress Semiconductor (CY) more.”

  • [By Paul Ausick]

    Noble Energy Inc. (NYSE: NBL) is rated a Buy and Jefferies raised the price target to $47. The 2017 net loss estimate was lowered from $0.40 per share to $0.22 per share. The 2018 EPS estimate was raised from $0.94 to $1.34. Shares closed at $36.71 on Friday, in a 52-week range of $28.82 to $42.03, and the consensus price target is $48.22.

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer sat down with David Stover, chairman and CEO of Noble Energy (NBL) , the oil exploration and production company with acreage in all of the best regions of the U.S.

  • [By Ben Levisohn]

    Noble Energy (NBL) soared to the top of the S&P 500 today after purchasing Clayton Williams Energy (CWEI) for $2.7 billion.

    Agence France-Presse/Getty Images

    Noble Energygained 7.1% to $40.05, while the S&P 500 fell 0.3% to2,267.89.

    Wunderlich’s Irene Haas explains why she’s a fan of the deal:

    Noble Energy (NBL) has agreed to acquire Clayton Williams Energy Inc. (CWEI-$103.98, Hold) for $3.4 billion. The transaction has been approved by both boards and should close during 2Q17. NBL will gain 71,000 net acres in Reeves County, production of 10,000 boepd, and 2,400 gross locations (with 8,000 lateral length) in the Wolfcamp, with net un-risked resource potential of over 1 billion boe. Netting out production, acreage outside of Reeves County, and midstream assets, NBL valued the Reeves County acreage at~$32,000 per net acre. NBL has the balance sheet and the technical expertise to develop the project quickly and generate meaningful production and cash flow growth. We reiterate our Buy rating on NBL.

    Noble Energy’s market capitalization rose to $17.2 billion from $16.1 billion on Friday. It reported a net lossof $2.4 billion on sales of $3 billion in 2015.

Top 10 Bank Stocks To Own For 2018: EPR Properties(EPR)

Advisors’ Opinion:

  • [By Laurie Kulikowski]

    We rate EPR PROPERTIES as a Buy with a ratings score of B. This is driven by a number of strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company’s strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. 

  • [By Laurie Kulikowski]

    The company, on the basis of net income growth from the same quarter one year ago, has significantly outperformed against the S&P 500 and exceeded that of the Real Estate Investment Trusts (REITs) industry average. The net income increased by 17.5% when compared to the same quarter one year prior, going from $42.71 million to $50.20 million.

     

  • [By Laurie Kulikowski]

    EPR’s revenue growth has slightly outpaced the industry average of 6.1%. Since the same quarter one year prior, revenues slightly increased by 9.7%. This growth in revenue appears to have trickled down to the company’s bottom line, improving the earnings per share.

     

  • [By Laurie Kulikowski]

    EPR’s investment pipeline should drive about 6-7% earnings growth in 2016, and historically the company’s dividend growth has roughly equated to earnings growth. Starting with an above-average 6.5% yield, we find this compelling for income-oriented investors. 

  • [By Laurie Kulikowski]

    Net operating cash flow has increased to $64.42 million or 19.61% when compared to the same quarter last year. The firm also exceeded the industry average cash flow growth rate of 9.39%.

    The gross profit margin for EPR PROPERTIES is currently very high, coming in at 73.12%. Regardless of EPR’s high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, EPR’s net profit margin of 46.18% significantly outperformed against the industry.

     

Top 10 Bank Stocks To Own For 2018: Alexco Resource Corp(AXU)

Advisors’ Opinion:

  • [By Cameron Saucier]

    Alexco Resource (NYSEMKT: AXU) operates in two segments: an environmental services business and a mining company. Its mining segment explores developments in Canada, while its environmental segment provides consulting and project management services in the United States and Canada. AXU is up over 400% YTD. The stock has been steadily rising since January. It isn’t clear what’s driving AXU upwards, other than general investor speculation. The stock is trading at $1.72 per share as of Monday intraday.

Top 10 Bank Stocks To Own For 2018: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested small cap manufacturing and 3D printing service provider ARC Group WorldWide (NASDAQ: ARCW) as a short trade:

Top 10 Bank Stocks To Own For 2018: McKesson Corporation(MCK)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    McKesson Corp. (NYSE: MCK), the leading pharmaceutical distributor, posted a revenue increase in the past year of $49.7 billion, up from $47.5 billion in ayear earlier. Its management offered hefty earnings for the quarter and year ahead. It continues to be a buyer of other companies, most recently Change Healthcare (which was labeled a merger with one of McKesson’s divisions). The current dividend is $1.12, or 0.61%.

  • [By Dan Caplinger]

    Drug-distribution specialist McKesson (NYSE:MCK) has had a tough year. Even as the overall stock market has climbed, the company’s shares have suffered, as investors fear that any business related to pharmaceuticals will have a political target on its back even under the current administration. Last quarter’s sluggish numbers didn’t create much enthusiasm for McKesson either.

  • [By Ben Levisohn]

    Clinton 15 stock basket (DBUSCLNT): UnitedHealth Group (UNH), Humana (HUM), McKesson (MCK), Aecom (ACM), Quanta Services (PWR), ExxonMobil (XOM), Alcoa (AA), NextEra Energy (NEE), Cree (CREE), First Solar (FSLR), Facebook (FB), Netflix (NFLX), Prudential Financial (PRU), Citigroup (C), Union Pacific (UNP).

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell by 1.77 percent. Meanwhile, top losers in the sector included McKesson Corporation (NYSE: MCK), down 24 percent, and Novo Nordisk A/S (ADR) (NYSE: NVO), down 13 percent.

Top 10 Bank Stocks To Own For 2018: WildHorse Resource Development Corporation (WRD)

Advisors’ Opinion:

  • [By Paul Ausick]

    WildHorse Resource Development Corp. (NYSE: WRD) raised $413 million on the sale of $27.5 million at $15 per share, well below the expected range of $19 to $21. Shares popped just 0.4% for the day and closed the week down 0.9%.

Top 10 Bank Stocks To Own For 2018: Telecom Argentina Stet – France Telecom S.A.(TEO)

Advisors’ Opinion:

  • [By Jim Robertson]

    Yesterday, our Under the Radar Moversportfolio newsletter suggested small cap telecommunications Telecom Argentina SA (NYSE: TEO) as a short/bearish trade:

  • [By Lisa Levin]

    Wednesday afternoon, the telecommunications services sector proved to be a source of strength for the market. Leading the sector was strength from Consolidated Communications Holdings Inc (NASDAQ: CNSL) and Telecom Argentina SA (ADR) (NYSE: TEO).

Top 10 Bank Stocks To Own For 2018: Fiat Chrysler Automobiles N.V.(FCAM)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The showstopper by far in the early going is Waymo’s self-driving minivan (pictured below) in partnership with Fiat Chrysler (FCAM) . Waymo’s ultimate mom-mobile, coming from a business that was spun-off from Google’s parent company Alphabet Inc. (GOOG) last month, is equipped with self-driving sensors and vision systems.

Top 10 Bank Stocks To Own For 2018: Medtronic plc(MDT)

Advisors’ Opinion:

  • [By Nelson Hem]

    Lawrence C. Strauss’s “Medtronic: Healthy and Getting Healthier” points out that some investors are skeptical about the prospects for this Dublin-based medical device maker. But are those investors underestimating the strength of Medtronic PLC (NYSE: MDT)? Find out why Barron’s believes the company’s shares could climb up to 15 percent over the next 12 months.

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Todd Campbell]

    At Medtronic (NYSE:MDT), one of the country’s largest medical-device companies, these sensors are even attached to an insulin pump patients wear that canautomatically administer insulin as it’s needed.

  • [By James E. Brumley]

    When an investor thinks of stocks in the cardio-monitoring arena, names like General Electric Company (NYSE:GE) and Medtronic PLC (NYSE:MDT) tend to surface first. And well they should. Medtronic is the largest name dedicated solely to equipment that tells doctors and nurses how well a patient’s heart is functioning, while GE Healthcare smartly leverages the name of its parent company’s recognizable name to win market share in the medical equipment space.

    General Electric and Medtronic aren’t the only names in town, however, and certainly not the top prospects for an investor seeking out a fresh, undiscovered growth opportunity. That honor arguably belongs to an up-and-coming small cap outfit called Biotricity Inc. (OTCMKTS:BTCY), which is nearing its first-ever revenue.

    Don’t look for a Biotricity product quite yet, as they’re not on the market. Consumers as well as investors will want to keep their eyes and ears open for two of them soon though, however, with one of those devices being a high-precision, FDA-approved instrument for use by healthcare workers in a clinical setting. The other device is a consumer-oriented version of the same technology, giving BTCY access to not just one but two crucial markets. Even more recently Biotricity reported it was opening up its development pipeline to the fetal monitoring and sleep apnea markets. Heart-monitoring is the near-term venture, though.

    The two products are called biotricity and biolife (neither moniker is supposed to be capitalized). The latter is a wireless, remote consumer-oriented heart rate and activity monitoring device, and the former is a clinical-grade monitoring device… also wireless and remotely operated/monitored.

    Bioflux is only available by prescription. The bioflux hardware includes an ECG (heart-rhythm) monitoring device, software, and if desired, service from a monitoring lab that performs remote diagnostic monitoring for up to 30 consecutive days at a time. It

  • [By Keith Fitz-Gerald]

    I’ve long thought that Medtronic (NYSE:MDT) would be a suitable buyer, as was the subject of unconfirmed rumors last month. However, I could also envision a defense contractor moving in simply because so much of the intellectual property could easily crossover to military applications. Or, even Google X for that matter.

  • [By Ben Levisohn]

    Cardinal Health (CAH) tumbled to the bottom of the S&P 500 today after agreeing to buy Medtronic’s (MDT) medical supplies business for $6.1 billion and offering disappointing guidance.

Top 10 Bank Stocks To Own For 2018: CBRE Group, Inc.(CBG)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of HAHN CAPITAL MANAGEMENT LLC’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=HAHN+CAPITAL+MANAGEMENT+LLC

    These are the top 5 holdings of HAHN CAPITAL MANAGEMENT LLCHexcel Corp (HXL) – 899,271 shares, 4.71% of the total portfolio. Shares reduced by 1.47%Mohawk Industries Inc (MHK) – 212,515 shares, 4.68% of the total portfolio. Shares reduced by 2.38%CBRE Group Inc (CBG) – 1,299,059 shares, 4.34% of the total portfolio. Shares reduced by 2.39%Becton, Dickinson and Co (BDX) – 241,184 shares, 4.25% of the total portfolio. Shares reduced by 2.37%Ross Stores Inc (ROST) – 642,103

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer also checked back in with Bob Sulentic, president and CEO of the real estate investment trust CBRE (CBG) , which has seen its stock rise 19% since Cramer last spoke with Sulentic just three months ago.

  • [By Lee Jackson]

    CBRE Group Inc. (NYSE: CBG) had a top hedge fund step in again last week and buy a huge block of shares. Value Act bought a total of 1,200,000 sharesat between $26.85 and $27.15. That cost the fund a gigantic $32 million.The companyoperates as a commercial real estate services and investment company worldwide, and its shares traded onFriday at $27.80.

  • [By WWW.THESTREET.COM]

    In his final “Executive Decision” segment, Cramer again welcomed Bob Sulentic, president and CEO of CBRE Group (CBG) , the real estate services company which reported a nine-cents-a-share earnings beat two weeks ago.